M&A activity continue to rise in Poland

Poland’s M&A market will see further recovery in the second half of the year, maintaining the upward trend seen in the first six months of 2014, according to a report by law firm Allen & Overy. “The Polish M&A market has been relatively lively in H1 2014 as compared to previous years. Although there have not been many megadeals we have seen a reasonable number of mid-size transactions, including the sale by Orkla Foods of one of its Polish subsidiaries, Delecta, to funds managed by Innova, as well as the sale by Advent of ULTIMO – a leading debt collection company,” the report reads. The report also said that more large, long-awaited deals should come out of the pipeline in the second half of the year, particularly in Q4. The deals currently on the radar include Montagu and Ares Life Sciences launching the sale of Euromedic, and Advent starting the sale process of American Heart of Poland. The industries attracting most investors’ attention are healthcare, retail as well as technology, media and telecommunications.